Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Arrhythmogenesis--a European perspective.

R W Campbell

    The American Journal of Cardiology
    |April 30, 1987
    PubMed
    Summary

    Antiarrhythmic therapy can cause new arrhythmias, a concern with varying definitions and causes. Geographic location influences drug availability and usage, impacting arrhythmogenic potential, with mexiletine showing the lowest risk.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Field work services in a residential school for the blind.

    Outlook for the blind and the teachers forum·2010
    Same author

    Effects of surgery for postinfarction ventricular tachycardia on parameters of left ventricular function.

    The American journal of cardiology·2002
    Same author

    Effects of intravenous dofetilide on induction of atrioventricular re-entrant tachycardia.

    Heart (British Cardiac Society)·2001
    Same author

    Thoracoscopic mapping and cryoablation of right ventricular tachycardia.

    Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology·2001
    Same author

    Time dependent variability of QT dispersion after acute myocardial infarction and its relation to ventricular fibrillation: a prospective study.

    Heart (British Cardiac Society)·2000
    Same author

    Evaluation of antiarrhythmic drug efficacy in patients with an ICD: unlimited potential or replete with complexity and problems?

    Journal of cardiovascular electrophysiology·1999

    Area of Science:

    • Cardiology
    • Pharmacology

    Background:

    • Arrhythmogenesis, the induction of arrhythmias by antiarrhythmic drugs, is an emerging clinical concern.
    • Current definitions of antiarrhythmic drug-induced arrhythmogenesis are insufficient.
    • This phenomenon is multifactorial and influenced by geographic variables.

    Purpose of the Study:

    • To explore the nuances of antiarrhythmic therapy-induced arrhythmogenesis.
    • To compare antiarrhythmic drug usage patterns and availability between Europe and the U.S.
    • To assess the arrhythmogenic potential of commonly used antiarrhythmic agents.

    Main Methods:

    • Review of current literature and clinical practices regarding antiarrhythmic therapy.
    • Comparative analysis of drug availability and usage in European and U.S. markets.
    • Evaluation of arrhythmogenic potential based on available data.

    Main Results:

    • Two main categories of arrhythmogenesis (clinical and technical) are recognized, though definitions remain unsatisfactory.
    • Antiarrhythmic drug usage is more conservative in Europe compared to the U.S.
    • Mexiletine, class IC agents, and sotalol are frequently used in Europe, all possessing arrhythmogenic potential, with mexiletine exhibiting the lowest.

    Conclusions:

    • Antiarrhythmic therapy-induced arrhythmogenesis is a significant issue requiring further definition and research.
    • Geographic differences in drug availability and prescribing practices influence the manifestation of this problem.
    • Mexiletine may represent a safer option regarding arrhythmogenic risk compared to class IC agents and sotalol.

    Related Experiment Videos